3 glp 1 drugs GLP-1 weight loss may be misused by patients with eating disorders: Study The GLP-1 revolution: What UAB

They need exogenous insulin to survive

Long-Term Efficacy and Adherence: The impact of novel oral formulations on sustained efficacy, weight maintenance, and patient compliance requires real-world assessment and comparative analyses

Clinical Trial Results: Tirzepatide (All Forms Mounjaro, Zepbound, Compounded): Because the active ingredient is identical, effectiveness is the same: SURMOUNT-1 Trial Results (72 weeks): 15 mg dose: 22.5% average body weight loss 10 mg dose: 21.4% average body weight loss 5 mg dose: 15.0% average body weight loss 96% of patients lost at least 5% of body weight 89% of patients lost at least 10% of body weight 63% of patients lost at least 20% of body weight Real-World Effectiveness: Compounded tirzepatide produces identical results to brand-name because its the same molecule at the same doses

7 Department of Medicinal Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk, 71491, Saudi Arabia

K., Hotz, V

Rare but serious risks, such as pancreatitis, must also be considered